EXTH-55. REPURPOSING THERAPEUTICS IN PATIENT-DERIVED GLIOMAS AND AN IDH1 MUTANT GLIOMA MODEL
Christin Schmidt(University of California, San Francisco), Anders I. Persson(University of California, San Francisco), Edith Yuan(University of California, San Francisco), Michelle R. Arkin(University of California, San Francisco), Steven Chen(University of California, San Francisco), Shirin IIkhanizadeh(University of California, San Francisco), Hanna Sabelström(University of California, San Francisco), William A. Weiss(City College of San Francisco), Andy S. Ding(Johns Hopkins Hospital), Mitchel S. Berger(University of California, San Francisco)
Cited by 0
Related Papers
Intertumoral Heterogeneity within Medulloblastoma Subgroups
|Cancer Cell|2017|1.3k
A Pharmacological Map of the PI3-K Family Defines a Role for p110α in Insulin Signaling
|Cell|2006|1.2k
Impact of Intraoperative Stimulation Brain Mapping on Glioma Surgery Outcome: A Meta-Analysis
|Journal of Clinical Oncology|2012|1k
Long-Range Photoinduced Electron Transfer Through a DNA Helix
|Science|1993|951